Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes – Endocrinology Advisor
Posted: June 11, 2017 at 6:46 pm
Endocrinology Advisor | Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes Endocrinology Advisor Hypogonadal men with type 2 diabetes (T2D) who were treated with testosterone undecanoate (TU) injections demonstrated reductions in glycated hemoglobin A1c (HbA1c) and anthropometric measures, according to data presented at the 77th American … |
Continue reading here:
Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes – Endocrinology Advisor
Related Post
- Male Hypogonadism | Endocrinology | Dartmouth-Hitchcock - November 7th, 2018
- Low Testosterone (Male Hypogonadism) | Cleveland Clinic - October 9th, 2018
- Hypogonadism? | Go Ask Alice! - October 9th, 2018
- Endo Pharmaceuticals | Hypogonadism - August 10th, 2018
- Hypogonadism disease: Malacards - Research Articles, Drugs ... - July 25th, 2018
- Male hypogonadism - You and Your Hormones - July 11th, 2018
- Hypogonadism (Low Testosterone) | Men's Health Resource Center - June 28th, 2018
- Late-onset hypogonadism - Wikipedia - April 1st, 2018
- Hypogonadism Treatment & Management: Approach Considerations ... - March 5th, 2018
- Hypogonadism: Practice Essentials, Background, Pathophysiology - February 13th, 2018
- Hypogonadism - UCSF Medical Center - February 4th, 2018
- Diminished Androgen and Estrogen Receptors and Aromatase ... - January 20th, 2018
- Healthier Andropause Build to Balance - January 20th, 2018
- Attention, Men: Doing This Every Day Could Lower Your ... - January 20th, 2018
- Lilly pulls Axiron from Korean market | Righting Injustice - January 20th, 2018
- Hypogonadism | Cleveland Clinic - December 30th, 2017
- Primary Hypogonadism VS Secondary Hypogonadism ... - December 29th, 2017
- Hypogonadism | Children's Hospital of Philadelphia - December 19th, 2017
- Male hypogonadism - Diagnosis and treatment - Mayo Clinic - December 17th, 2017
- Hypogonadism Causes & Information | Cleveland Clinic - December 12th, 2017
- Low Testosterone | Hormone Health Network - November 24th, 2017
- Induction of fertility in men with secondary hypogonadism - November 4th, 2017
- Hypogonadism, Male | ARUPConsult Lab Test Selection - October 19th, 2017
- Hypogonadism Testosterone Therapy Treatment | Ageonics Medical - October 19th, 2017
- Hypogonadism: Types, Causes, & Symptoms - healthline.com - October 13th, 2017
- Male Hypogonadism Drug Market Analysis, Share and Size, Trends, Industry Growth And Segment Forecasts To 2021 - satPRnews (press release) - September 6th, 2017
- Asia-Pacific Male Hypogonadism Market by Region, Production, Consumption, Revenue, Market Share and Growth ... - satPRnews (press release) - September 6th, 2017
- Male hypogonadism - Treatment - Mayo Clinic - August 30th, 2017
- Wives of 3 of 4 patients treated for hypogonadism conceive - Times of India - August 22nd, 2017
- Pipeline Landscape of Male Hypogonadism Covering Therapeutic Assessment and Drug Portfolio in 2017 - Digital Journal - August 17th, 2017
- Long-term testosterone therapy improves urinary, sexual function and quality of life - Medical Xpress - August 15th, 2017
- Male Hypogonadism Sales Market Research Report 2017 to 2022 - The Donohue Report - August 12th, 2017
- Lipocine resubmits NDA for LPCN 1021 in hypogonadism - The Pharma Letter (registration) - August 12th, 2017
- 3 Things In Biotech You Should Learn Today: August 12, 2017 - Seeking Alpha - August 12th, 2017
- Male Hypogonadism Market Growth Forecast Analysis by ... - Green Mountain Outlook - August 12th, 2017
- Global Male Hypogonadism Market 2017 Allergan Plc., Endo International Plc., Ferring, AbbVie Inc. - DailyCommerceNews - August 10th, 2017
- Here's What Lipocine Inc. (NASDAQ:LPCN)'s Latest Announcement Means For Shareholders - Market Exclusive - August 10th, 2017
- Lipocine (LPCN) Resubmits NDA for Oral Testosterone Product Candidate, LPCN 1021, for Treatment of Hypogonadism - StreetInsider.com - August 9th, 2017
- Global Male Hypogonadism Market 2017- Astrazeneca Plc., Merck & Co. Inc., Laboratories Genevrier, Allergan Plc. - DailyCommerceNews - August 8th, 2017
- Male Hypogonadism Market Research Report 2017 To 2022 - Equity Insider (press release) - August 4th, 2017
- Male Hypogonadism Market Set for Expansive Growth over Next 10 Years - Digital Journal - August 3rd, 2017
- Research details developments in the male hypogonadism - market ... - WhaTech - August 2nd, 2017
- Male Hypogonadism Pipeline Report, H1 2017 - Therapeutics Review of 15 Companies & Drug Profiles - Research ... - Business Wire (press release) - July 11th, 2017
- Man, 34, 'DOUBLES the size of his penis in nine months thanks to hormone injections' - The Sun - June 29th, 2017
- Man Doubles Penis Size After Testosterone Injections To Treat Hypogonadism Condition - Medical Daily - June 29th, 2017
- Male Hypogonadism Market predicts rise in demand by 2016-2024 - People Today 24 - June 23rd, 2017
- Lipocine (LPCN) Spikes On Testosterone Dosing Data - Economic Calendar - June 21st, 2017
- Nasal Testosterone Gel Shown to Normalize Androgen Levels, Improve Erectile Function & Mood in Hypogonadal Men - UroToday - June 21st, 2017
- Hormone Treatments Helps Man's Penis DOUBLE In Size - YourTango - June 20th, 2017
- Assessment of Hypogonadism in Men With Type 2 Diabetes: A Cross-Sectional Study From Saudi Arabia. - UroToday - June 19th, 2017
- Low Testosterone Treatments | Houston TX - June 18th, 2017
- Testosterone Support Still Going Strong in Men's Supplements ... - Nutritional Outlook - June 18th, 2017
- Acerus Announces Licensing of NATESTO - Business Wire (press release) - June 14th, 2017
- Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in ... - UroToday - June 14th, 2017
- Long-Term Testosterone Tx Assessed in Men With Hypogonadism and T2D - Monthly Prescribing Reference (registration) - June 13th, 2017
- Virtual graphic card for games 3d analyzer - Top rated online casinos for us players - Online live casino deutschland - Microfinance Monitor - June 13th, 2017
- Acerus Announces NATESTO License Agreement with Therios ... - Business Wire (press release) - June 11th, 2017
- ASCO 2017: Prostate cancer in 696 hypogonadal men with and without long-term testosterone therapy: Results from a ... - UroToday - June 9th, 2017
- Low testosterone risk flagged for testicular cancer survivors - medwireNews - June 9th, 2017
- Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the ... - UroToday - May 31st, 2017
- External Beam Radiotherapy Affects Serum Testosterone in Patients ... - UroToday - May 31st, 2017
- The Ball's In Your Court - Lexology (registration) - May 25th, 2017
- Hypogonadism Hormone Health Network - May 23rd, 2017
- AUA 2017: Calculated Free T and T:E Ratio but not Total Testosterone and Estradiol Predict Low Libido - UroToday - May 21st, 2017
- AUA 2017: Prevalence of Hormonal Abnormalities in Young Men with Erectile Dysfunction - UroToday - May 21st, 2017
- Hypogonadism Treatment & Management: Approach ... - May 20th, 2017
- AUA 2017: The Effect of Shift Work on a Man's Sexual and Urologic Health - UroToday - May 19th, 2017
- The Effect of Shift Work on a Man's Sexual and Urologic Health - PR Newswire (press release) - May 13th, 2017
- Adherence to Topical Testosterone Therapy in Primary and Secondary Hypogonadism - Endocrinology Advisor - May 12th, 2017
- AYTU BIOSCIENCE, INC. (OTCMKTS:AYTU) Files An 8-K Results of Operations and Financial Condition - Market Exclusive - May 12th, 2017
- 19 foods that lower testosterone levels - Bel Marra Health - May 12th, 2017
- AYTU BIOSCIENCE, INC. (OTCMKTS:AYTU) Files An 8-K Entry into a Material Definitive Agreement - Market Exclusive - May 10th, 2017
- In Hypogonadism, Stroke May Be Prevented With Testosterone Replacement Therapy - Neurology Advisor - May 9th, 2017
- What's in the Cards for Repros (RPRX) this Earnings Season? - Zacks.com - May 5th, 2017
- Testosterone Replacement Therapy May Protect Against Stroke, Heart Attack in Hypogonadism - Endocrinology Advisor - May 5th, 2017
- Aytu BioScience to Provide Fiscal Third Quarter 2017 Business Update - PR Newswire (press release) - May 3rd, 2017
- Global Male Hypogonadism Market, 20162024: Type. Size, Share, Trends & Forecast Report - satPRnews (press release) - April 27th, 2017
- Global Male Hypogonadism Market, 20162024: Type. Size, Share, Trends & Forecast Report - MilTech - April 26th, 2017
- Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms ... - UroToday - April 25th, 2017
- XOMA Announces Positive Results from its Phase 2 Proof-Of ... - Yahoo Finance - April 24th, 2017